Dyadic Announces Sale of Equity Interest in Alphazyme
19. Januar 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
DNases, Ligases, and RNA Polymerases Market Research Report 2022: Focus on DNases-Biopharmaceutical Processing & Ligases-Oligonucleotide Synthesis - Forecast to 2030
30. Dezember 2022 04:03 ET
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "DNases, Ligases, and RNA Polymerases Market Size, Share & Trends Analysis Report by Application (DNases-Biopharmaceutical Processing,...